|
⚲
|
| Keyboard |
| David Bearss | |
|---|---|
| Firm | |
| Address | 3900 N Traverse Mountain Blvd Suite 100 Lehi, UT 84043 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Halia Therapeutics Inc | 021-552038 | Executive Officer | 0.3 M of 20.0 M |
||
| Canary Speech Inc | 021-481934 | Director | 1.9 M of 1.9 M |
||
| Halia Therapeutics Inc | 021-469248 | Executive Officer | 12.2 M of 50.0 M |
||
| Canary Speech Inc | 021-446445 | Director | 2.8 M of 2.8 M |
||
| Biolexis Therapeutics Inc | 021-435320 | Executive Officer | 1.5 M of 2.0 M |
||
| Xenter Inc | 021-406110 | Executive Officer | 19.6 M of 20.0 M |
||
| Reglagene Holding Inc | 021-406057 | Director | 0.6 M of 1.5 M |
||
| Scientia Vascular LLC | 021-402432 | Director | 50.0 M of 50.0 M |
||
| Halia Therapeutics Inc | 021-389700 | Executive Officer | 5.0 M of 5.0 M |
||
| Halia Therapeutics Inc | 021-378597 | Executive Officer | 6.3 M of 15.0 M |
||
| Salarius Pharmaceuticals LLC | 021-274899 | Executive Officer | 0.1 M of 0.1 M |
||
| Salarius Pharmaceuticals LLC | 021-274897 | Executive Officer | 0.1 M of 0.1 M |
||
| Salarius Pharmaceuticals LLC | 021-260594 | Director | 0.8 M of 2.7 M |
||
| Tolero Pharmaceuticals Inc | 021-181891 | Executive Officer | 3.3 M of 13.9 M |
||